Genetic testing and diagnosis increases the precision of an infertility specialist's diagnostic capability. Such precision is needed to guide treatment protocols. We rely on accurate tools such as Reprogenetics' Array-CGH to customize treatment plans for each patient because time is of the essence, and tests with greater range of variability can result in mediocre treatment plans and ultimately unnecessary waste of energy and resources, not to mention prolonging treatment.
There are many reasons we use Reprogenetics. Reprogenetics is the only genetics laboratory that publishes a lot of research. Diagnostic tests need to be validated with research. That involves putting a group of patients through different experimental diagnostic tests and comparing the outcome of those tests to the "gold standard." The diagnostic tests that have greater "power" to detect their intended targets have greater reliability and predictive value. On the other hand, those tests that have not gone through research validation are considered "non-validated."
The Array CGH is now the only pre-implantation genetic diagnosis (PGD) test that is "validated." Acacio Fertility Center does not recommend "non-validated" diagnostic testing technologies.